Advertisement
Loading...

Embecta Corp.

EMBCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.14
$0.00(0.00%)
U.S. Market opens in 28h 26m

Embecta Corp. (EMBC) Stock Overview

Explore Embecta Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap186.3M
P/E Ratio1.64
EPS (TTM)$1.91
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$8.70
3 Months$3.99
1 Year Target$10.74

EMBC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Embecta Corp. (EMBC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 14.21, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $10.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 1.64 and a market capitalization of 186.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-13.50%
1-Month Change
-67.33%
3-Month Change
-69.12%
6-Month Change
-78.42%
Year-to-Date (YTD) Change
-73.57%
1-Year Change
-73.07%
3-Year Change
-89.06%
5-Year Change
-93.32%
All-Time (Max) Change
-93.32%

Contact Information

201 847 6880
300 Kimball Drive, Parsippany, NJ, 07054

Company Facts

2,000 Employees
IPO DateMar 22, 2022
CountryUS
Actively Trading

Frequently Asked Questions